Onset and rate of striatal atrophy in preclinical Huntington disease.
about
The palmitoyl acyltransferase HIP14 shares a high proportion of interactors with huntingtin: implications for a role in the pathogenesis of Huntington's diseaseMultiple Aspects of Gene Dysregulation in Huntington's DiseaseMagnetic resonance imaging striatal volumes: a biomarker for clinical trials in Huntington's diseaseAltered hypothalamic protein expression in a rat model of Huntington's diseaseExtensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease miceExpression analysis of novel striatal-enriched genes in Huntington disease.Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis.Longitudinal change in regional brain volumes in prodromal Huntington diseaseA novel cognitive-neurophysiological state biomarker in premanifest Huntington's disease validated on longitudinal data.Functional magnetic resonance imaging of working memory in Huntington's disease: cross-sectional data from the IMAGE-HD study.Multi-modal neuroimaging in premanifest and early Huntington's disease: 18 month longitudinal data from the IMAGE-HD study.Neuroimaging and therapeutics in movement disorders.Brain Diffusivity and Structural Changes in the R6/2 Mouse Model of Huntington Disease.Time processing in Huntington's disease: a group-control studyFunctional imaging in Huntington's disease.Magnetic resonance imaging of Huntington's disease: preparing for clinical trials.Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.Neural correlates of impaired emotion processing in manifest Huntington's disease.Seeking brain biomarkers for preventive therapy in Huntington disease.Complexity and heterogeneity: what drives the ever-changing brain in Huntington's disease?Automatic detection of preclinical neurodegeneration: presymptomatic Huntington disease.Magnetization transfer imaging in 'premanifest' Huntington's diseaseQEEG Measures in Huntington's Disease: A Pilot Study.Striatal structure and function in mood disorders: a comprehensive review.Use of Genetically Altered Stem Cells for the Treatment of Huntington's Disease.Neuropsychiatric Burden in Huntington's Disease.Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease."Frontal" behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awareness.Progression in prediagnostic Huntington disease.Contrasting gray and white matter changes in preclinical Huntington disease: an MRI study.Radiation absorbed dose to the basal ganglia from dopamine transporter radioligand 18F-FPCIT.Differential putaminal morphology in Huntington's disease, frontotemporal dementia and Alzheimer's disease.Frontal cortex BOLD signal changes in premanifest Huntington disease: a possible fMRI biomarker.The effect of interference on temporal order memory in premanifest and manifest Huntington's diseaseFreeSurfer-initiated fully-automated subcortical brain segmentation in MRI using Large Deformation Diffeomorphic Metric MappingFunctional connectivity of primary motor cortex is dependent on genetic burden in prodromal Huntington disease.Neuropsychological deficits in Huntington's disease gene carriers and correlates of early "conversion".Regionally selective atrophy of subcortical structures in prodromal HD as revealed by statistical shape analysis.Abnormal explicit but normal implicit sequence learning in premanifest and early Huntington's disease.Estimating premorbid functioning in huntington's disease: the relationship between disease progression and the wide range achievement test reading subtest.
P2860
Q24293871-CFD7700B-5BE9-4662-9B75-AC3465B3DE73Q24605880-0A170E5B-8052-4D85-B2A1-49036AE0036DQ27004343-F64C8E3C-4A65-4571-90F9-D6A498678531Q27314833-2E0DF516-8830-43C8-A738-76BB5C8F5AFDQ30437914-B74DB615-F0B3-4DC3-B092-26F3E10942AAQ30476999-CC944AEB-46A0-4EA2-8851-8A349FA731C9Q30497024-E633B7AF-2D6B-490D-BD0C-B2C2813D5DA1Q30500786-C19EEB4E-BFF4-46FB-A8CC-86F470ADE663Q30622209-7F186F82-05C9-46FC-ACE0-0C179ADDC829Q30659199-F268C5C3-DE30-4CBE-BAC9-26C5A686B2D1Q30670030-76DE630D-EC5C-418A-8A5C-D484E2131A76Q30989947-2A48A96E-6AD4-4E7A-B981-A0053EADB7CAQ31136004-492FA0A3-8333-4B27-A5B6-993DD72F2D77Q33308722-D69CF22C-6472-4477-BE6F-322FF35B7459Q33403110-6D97EB0E-02F5-4167-AC2C-B08A351E3767Q33437923-F318B460-06F5-434F-990A-3672ADE633ABQ33489152-23F36FDE-2778-44E3-8057-B91CB5555DA1Q33582389-F38F2050-823E-43B4-BDA4-20C470EFBDC9Q33606063-15D50BA4-0AE9-4C7E-B1C5-38E8BF132BF6Q33619310-7FB47CB9-6D4E-4C0F-A391-0A6D158804E2Q33635548-EFD3F72C-1589-4262-A731-C3A42E074C92Q33724810-A729A3A4-C305-4FD5-AD0A-1F3599946DAFQ33734662-14E76967-520D-4839-888E-8DDCF8664F6CQ33777327-CC27568C-85AD-40C4-B070-86F892F011D6Q33788929-19F15DB6-2AF8-468F-9687-D02020587DECQ33831793-CF50185C-CD86-48A7-A198-6B5C3DBB13DFQ33832866-5F3BE14B-1A02-4206-8B9E-0551DDFEE47CQ33854599-508EE3D5-F290-428E-908B-478E44375515Q33861265-5D4FFF9D-DB7E-4A30-9152-F5623C5AE351Q33861321-BD84DCC3-B3E4-4B8B-8B07-8564B8621BEDQ33908527-38C0EBF3-B2C5-429B-A07D-D099DD2A8F76Q33959500-C8CD5A8F-554B-480F-B5C0-93ECD746F713Q33965402-414381E3-632E-48B5-9E5D-E512E2DCB882Q33974767-933AA801-830C-4FFC-8E29-69C36B656F58Q33999738-874D975E-8A3B-4021-B010-AB0426A1E5C6Q34096680-DB2E79F0-28BD-42A3-A402-F868583AEBE7Q34252105-72226343-9789-4B06-832F-D5E3469BE0C2Q34320446-08F92E44-EFD5-4CD3-886A-3E93B7D294EDQ34383538-0BD838F4-8DDB-46FB-BE24-A2E810F0F796Q34495971-0EF8AD9F-A1F5-4BAC-BF77-82AB22BB967E
P2860
Onset and rate of striatal atrophy in preclinical Huntington disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Onset and rate of striatal atrophy in preclinical Huntington disease.
@en
type
label
Onset and rate of striatal atrophy in preclinical Huntington disease.
@en
prefLabel
Onset and rate of striatal atrophy in preclinical Huntington disease.
@en
P2093
P1433
P1476
Onset and rate of striatal atrophy in preclinical Huntington disease.
@en
P2093
Aylward EH
Gourley LM
Margolis RL
Rosenblatt A
Shpritz BD
P356
10.1212/01.WNL.0000132965.14653.D1
P407
P577
2004-07-01T00:00:00Z